LightPath Technologies, Inc. — Form 10-Q Summary
Reporting period: Fiscal third quarter and nine months ended March 31, 2023, compared with the periods ended March 31, 2022. The supplied filing is for 2023 Q3, notwithstanding the request metadata’s “2022 Q3.” LightPath manufactures optical components and assemblies, with operations in the United States, China, and Latvia.
Financial performance
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Revenue | $7.41 million, down 11% year over year | $23.25 million, down 13% |
| Gross margin | $2.54 million; 34% of revenue, versus 37% | $7.99 million; 34%, versus 34% |
| Operating loss | $0.96 million, versus $0.46 million | $2.75 million, versus $1.84 million |
| Net loss | $1.16 million, or $0.03 per share, versus $0.50 million, or $0.02 | $3.24 million, or $0.11 per share, versus $2.18 million, or $0.08 |
| EBITDA (non-GAAP) | Loss of $0.24 million, versus income of $0.65 million | Loss of $0.43 million, versus income of $1.06 million |
Quarterly revenue declines were led by precision molded optics (PMO), down 23%; infrared revenue fell 3%, while specialty products rose 28%. For the nine months, PMO revenue declined 12% and infrared revenue declined 18%; specialty revenue increased 27%. Management attributed weakness to lower telecommunications and commercial demand, softer China sales, timing of a large infrared contract, and temporary Orlando production disruption during facility construction. The renewed infrared contract is 20% larger than its predecessor, with shipments beginning late in the quarter.
Quarterly gross margin percentage decreased, which management attributed to lower revenue and a less favorable mix weighted toward lower-margin infrared products. Year-to-date gross margin percentage was maintained despite lower sales. SG&A was $2.76 million for the quarter, up 5%, and $8.43 million year to date, approximately flat. Interest expense increased with higher rates and loan-fee amortization.
Cash, liquidity, and capital
- At March 31, 2023, cash and cash equivalents were $9.90 million, working capital was approximately $16.0 million, and total assets were $55.32 million. More than 25% of cash was held by foreign subsidiaries; repatriation from China is subject to restrictions.
- Operating cash flow was negative $0.92 million for the nine months, versus positive $0.35 million a year earlier, principally reflecting a $1.32 million inventory increase amid Orlando construction disruption. Investing cash outflow was $2.26 million, including $2.33 million of property and equipment purchases.
- Financing provided $7.53 million, including $9.20 million of net proceeds from a January public stock offering, partly offset by loan and finance-lease repayments. Shares outstanding increased from 27.05 million at June 30, 2022 to 37.23 million at March 31, 2023; the filing reports 37.33 million outstanding as of May 8, 2023.
- Loans payable were approximately $2.63 million, including about $2.4 million on the BankUnited term loan and $0.28 million on an equipment loan. BankUnited’s prime rate was 7.75% at quarter-end. The term loan maturity was extended to December 31, 2024, with monthly payments of $75,000 through December 2023 and $100,000 beginning January 2024. Financial covenant compliance was waived through December 31, 2023.
- Operating lease liabilities were approximately $9.63 million. The company estimated $1.3 million of remaining Orlando facility tenant-improvement costs for fiscal Q4, in addition to $1.2 million spent through Q3; the landlord agreed to provide $2.4 million in allowances.
Outlook, commentary, and risks
- No specific revenue or earnings guidance is provided. Management said the January equity raise should avoid the need for additional equity capital “for the foreseeable future,” while noting revenue shortfalls, cost increases, unrealized efficiency gains, or strategic transactions could create future funding needs.
- Backlog was $26.62 million at March 31, up 35% year over year and 50% from fiscal year-end, but down 10% from the prior quarter. It included a $4 million European customer supply agreement expected to run about 12–18 months from fiscal Q4, a $2.5 million initial order for an international military program, and the renewed infrared contract. Management anticipates existing annual and multi-year contracts will be renewed, but timing can cause backlog to fluctuate.
- Management expects the remaining Orlando construction phases to be minimally disruptive. Risks include China’s weaker economy and demand, lingering COVID-related travel and operating constraints, supply availability and cost inflation, geopolitical disruption including the Russia-Ukraine conflict, foreign-exchange movements, and the company’s ability to grow sales, convert inventory to cash, and execute efficiency improvements.
- Unusual or notable items: the January share offering materially diluted shareholders; construction affected production and increased inventory; the company incurred approximately $129,000 in Orlando facility exit costs and $53,000 in BankUnited fees during the nine months. The filing also reports a May 9, 2023 BankUnited amendment, after quarter-end, releasing most loan collateral while retaining a $2.46 million cash collateral account and removing certain restrictions and financial covenants.
- Legacy legal proceedings involving former China subsidiary employees remain described in the notes; related severance was paid to the court in October 2022. Management expects minimal further legal and consulting costs and reports no material operational impact. Management concluded disclosure controls were effective as of March 31, 2023.
Important facts for investors to verify
- Whether backlog orders convert to revenue on the anticipated schedule, and whether major customer contracts renew or ship as expected.
- Whether Orlando construction is completed on budget and remaining production disruption and tenant-improvement spending are limited.
- Whether operating cash flow improves as inventory is converted to sales, particularly given the year-to-date cash use from operations.
- Available and accessible liquidity, including foreign cash repatriation limits, the BankUnited cash collateral, debt service, and the post-quarter loan amendment terms.
- Drivers of weaker PMO and infrared sales, especially China demand and the timing and economics of large contracts, alongside the effects of equity issuance and share dilution.